Petition for Inter Partes Review by Baxter Healthcare Corp. of Millenium Biologix, LLC’s Patent No. RE41,251 (Final Written Decision)

Defendant: Millenium Biologix, LLC

Court: Patent Trial and Appeal Board

Date: Mar 24, 2015

Docket: IPR2013-00582

Judge: Brian P. Murphy

March 18, 2015 – In a Final Written Decision, the Board found the challenged claims unpatentable

March 21, 2014 – Inter Partes Review instituted

September 16, 2013 – Baxter files Petition for Inter Partes Review of Claims 1, 6, and 8-13

Decision Instituting Inter Partes Review [351.66 kB]
Final Written Decision [586.24 kB]
Petition for Inter Partes Review [253.69 kB]
RE41,251 [3.81 MB]
Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity